These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3754099)

  • 1. Importance of the level of paralysis recovery for a rapid antagonism of atracurium neuromuscular blockade with moderate doses of edrophonium.
    Hennart D; d'Hollander A; Plasman C; De Jonckheere M
    Anesthesiology; 1986 Mar; 64(3):384-7. PubMed ID: 3754099
    [No Abstract]   [Full Text] [Related]  

  • 2. Recovery characteristics following antagonism of atracurium with neostigmine or edrophonium.
    Jones RM; Pearce AC; Williams JP
    Br J Anaesth; 1984 May; 56(5):453-7. PubMed ID: 6326785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of atracurium with edrophonium.
    Baird WL; Kerr WJ
    Br J Anaesth; 1983; 55 Suppl 1():63S-66S. PubMed ID: 6688019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profound atracurium induced neuromuscular blockade. A comparison of evoked reversal with edrophonium or neostigmine.
    Casson WR; Jones RM
    Anaesthesia; 1986 Apr; 41(4):382-5. PubMed ID: 3754698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular and autonomic nervous effects of edrophonium and atropine combinations during neuromuscular blockade antagonism in sheep.
    Clutton RE; Glasby MA
    Vet Anaesth Analg; 2008 May; 35(3):191-200. PubMed ID: 18282258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonism of atracurium-induced neuromuscular blockade by neostigmine or edrophonium.
    Astley BA; Hughes R; Payne JP
    Br J Anaesth; 1986 Nov; 58(11):1290-5. PubMed ID: 3778793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neostigmine and edrophonium antagonism of varying intensity neuromuscular blockade induced by atracurium, pancuronium, or vecuronium.
    Rupp SM; McChristian JW; Miller RD; Taboada JA; Cronnelly R
    Anesthesiology; 1986 Jun; 64(6):711-7. PubMed ID: 2872839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of edrophonium and neostigmine for the antagonism of atracurium-induced neuromuscular block.
    Lavery GG; Mirakhur RK; Gibson FM
    Anesth Analg; 1985 Sep; 64(9):867-70. PubMed ID: 3161421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-response relationships for edrophonium and neostigmine antagonism of atracurium and cisatracurium-induced neuromuscular block.
    Naguib M; Riad W
    Can J Anaesth; 2000 Nov; 47(11):1074-81. PubMed ID: 11097536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recovery times following edrophonium and neostigmine reversal of pancuronium, atracurium, and vecuronium steady-state infusions.
    Kopman AF
    Anesthesiology; 1986 Dec; 65(6):572-8. PubMed ID: 2878631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid chemical antagonism of neuromuscular blockade by L-cysteine adduction to and inactivation of the olefinic (double-bonded) isoquinolinium diester compounds gantacurium (AV430A), CW 002, and CW 011.
    Savarese JJ; McGilvra JD; Sunaga H; Belmont MR; Van Ornum SG; Savard PM; Heerdt PM
    Anesthesiology; 2010 Jul; 113(1):58-73. PubMed ID: 20526187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Edrophonium antagonism of cisatracurium-induced neuromuscular block: dose requirements in children and adults.
    Abdulatif M; El-Sanabary M
    Anaesth Intensive Care; 2001 Aug; 29(4):364-70. PubMed ID: 11512646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonism of profound neuromuscular blockade induced by vecuronium or atracurium. Comparison of neostigmine with edrophonium.
    Caldwell JE; Robertson EN; Baird WL
    Br J Anaesth; 1986 Nov; 58(11):1285-9. PubMed ID: 2877681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of atracurium in anaesthetized man.
    Payne JP; Hughes R
    Br J Anaesth; 1981 Jan; 53(1):45-54. PubMed ID: 7459185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Edrophonium effectively antagonizes neuromuscular block at the laryngeal adductors induced by rapacuronium, rocuronium and cisatracurium, but not mivacurium.
    Suzuki T; Lien CA; Belmont MR; Tjan J; Savarese JJ
    Can J Anaesth; 2003 Nov; 50(9):879-85. PubMed ID: 14617582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The maximum depth of an atracurium neuromuscular block antagonized by edrophonium to effect adequate recovery.
    Beemer GH; Goonetilleke PH; Bjorksten AR
    Anesthesiology; 1995 Apr; 82(4):852-8. PubMed ID: 7717555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atracurium in clinical anaesthesia.
    Rowlands DE
    Br J Anaesth; 1983; 55 Suppl 1():125S-128S. PubMed ID: 6688006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recovery of spontaneous breathing following neuromuscular blockade with atracurium.
    Hackett GH; Hughes R; Payne JP
    Br J Anaesth; 1986 May; 58(5):494-7. PubMed ID: 3083848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neostigmine and edrophonium. Antagonism of profound and shallow mivacurium blockade].
    Bartunek A; Gilly H; Huemer G; Yildiz S; Schramm W; Lackner FX; Foldes FF
    Anaesthesist; 1997 Feb; 46(2):96-100. PubMed ID: 9133184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atracurium in anaesthetized man.
    Foldes FF
    Br J Anaesth; 1981 Dec; 53(12):1366. PubMed ID: 6965263
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.